Kinnevik Investment


Babylon goes the SPAC route, Kinnevik to book SEK1.8bn in excess value

03/06/21 -"Following the holding company’s 31 May ad hoc announcement regarding a potential listing of Babylon Health, Kinnevik has just confirmed that the company will go public through a SPAC merger ..."

Pages
58
Language
English
Published on
03/06/21
You may also be interested by these reports :
19/11/26
Sonae released very strong Q3 26 results, particularly impressive in food retail compared to peer Jeronimo Martins. This strong operational ...

19/11/26
Since our last teaser, (already 3 years old…), D’Ieteren (ADD, 16% UPSIDE) has continued to outperform the Stoxx 600 and the Holding Universe thanks ...

17/11/26
We have increased our TP on DB1 as a result of our EPS upgrade. We have upgraded our EPS projections following strong Q3-26 results, accounting for ...

16/11/26
We have upgraded our EPS estimates on Euronext across our forecast horizon (+12% vs our previous projections in 2026, +13% in 2027, and +15% in ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO